This document explores how advanced analytics transform clinical trial safety monitoring and pharmacovigilance. It highlights challenges such as fragmented safety data, delayed signal detection, and reliance on static reports. Revvity Signals solutions leverage Spotfire-powered analytics to aggregate clinical, operational, and safety data in near real time, enabling proactive identification of emerging risks. The paper details tools such as Clinical Data Review, Line Listing Review, and pharmacovigilance analytics that support flexible querying, visualization, and collaboration. By applying Bayesian and statistical signal detection methods across large datasets, organizations can better assess adverse event trends throughout a drug’s lifecycle. The approach improves decision-making, regula

Join for free to read